ICU Medical, Inc. (ICUI)

Stock Price Forecast

There is currently no analyst price target forecast available for ICU Medical.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

The average analyst rating for ICU Medical stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Apr '23	May '23	Jun '23	Jul '23	Aug '23	Sep '23
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Mishan Keybanc	Keybanc	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 9, 2023
Jayson Bedford Raymond James	Raymond James	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Nov 8, 2022
Jayson Bedford Raymond James	Raymond James	Buy Maintains $208 → $190	Buy	Maintains	$208 → $190	+62.49%	Aug 9, 2022
Matthew Mishan Keybanc	Keybanc	Buy Maintains $230 → $225	Buy	Maintains	$230 → $225	+92.42%	Aug 9, 2022
Jayson Bedford Raymond James	Raymond James	Buy Maintains $235 → $208	Buy	Maintains	$235 → $208	+77.88%	Aug 8, 2022

Full Analyst Rating History

Financial Forecast

Revenue This Year

2.30B

Increased by 0.66%

from 2.28B

Revenue Next Year

2.39B

Increased by 4.14%

from 2.30B

EPS This Year

6.68

from -3.11

EPS Next Year

7.62

Increased by 14.12%

from 6.68

Year	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027
Revenue	1.40B	1.27B	1.27B	1.32B	2.28B	2.30B	2.39B	2.48B	2.70B	2.77B
Revenue Growth	8.31%	-9.56%	0.38%	3.56%	73.21%	0.66%	4.14%	3.68%	8.76%	2.67%
EPS	1.33	4.69	4.02	4.74	-3.11	6.68	7.62	9.69	12.14	14.04
EPS Growth	-59.57%	252.63%	-14.29%	17.91%	-	-	14.12%	27.09%	25.26%	15.63%
No. Analysts	-	-	-	-	-	6	6	4	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2023	2024	2025	2026	2027
High	2.4B	2.5B	2.6B	2.8B	2.8B
Avg	2.3B	2.4B	2.5B	2.7B	2.8B
Low	2.2B	2.3B	2.4B	2.6B	2.7B

Revenue Growth

Revenue Growth	2023	2024	2025	2026	2027
High	5.2%	8.5%	7.7%	11.9%	5.7%
Avg	0.7%	4.1%	3.7%	8.8%	2.7%
Low	-4.1%	-1.4%	-1.3%	4.5%	-1.3%

EPS Forecast

EPS	2023	2024	2025	2026	2027
High	6.98	8.15	10.21	12.50	14.45
Avg	6.68	7.62	9.69	12.14	14.04
Low	6.31	6.90	9.09	11.66	13.48

EPS Growth

EPS Growth	2023	2024	2025	2026	2027
High	-	22.0%	33.9%	28.9%	19.0%
Avg	-	14.1%	27.1%	25.3%	15.6%
Low	-	3.3%	19.3%	20.4%	11.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.